The most frequently detected mutations in the LQTS -related genes, KCNQ1, KCNH2, and SCN5A show a strong genotype-phenotype relationship, with a high corresponding risk of symptoms, which is one of the reasons why effective therapeutic options for mutations in these genes have been thoroughly investigated [7]. This evidence concerns the gene KCNH2 and familial long QT syndrome.